JPH038322B2 - - Google Patents

Info

Publication number
JPH038322B2
JPH038322B2 JP57114946A JP11494682A JPH038322B2 JP H038322 B2 JPH038322 B2 JP H038322B2 JP 57114946 A JP57114946 A JP 57114946A JP 11494682 A JP11494682 A JP 11494682A JP H038322 B2 JPH038322 B2 JP H038322B2
Authority
JP
Japan
Prior art keywords
nicardipine
dihydropyridine
effect
present
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57114946A
Other languages
English (en)
Japanese (ja)
Other versions
JPS597163A (ja
Inventor
Isao Oohata
Nobuo Sakamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP57114946A priority Critical patent/JPS597163A/ja
Priority to US06/507,024 priority patent/US4565823A/en
Publication of JPS597163A publication Critical patent/JPS597163A/ja
Publication of JPH038322B2 publication Critical patent/JPH038322B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
JP57114946A 1982-07-02 1982-07-02 抗動脈硬化剤 Granted JPS597163A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP57114946A JPS597163A (ja) 1982-07-02 1982-07-02 抗動脈硬化剤
US06/507,024 US4565823A (en) 1982-07-02 1983-06-23 Medical agent for suppressing arteriosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57114946A JPS597163A (ja) 1982-07-02 1982-07-02 抗動脈硬化剤

Publications (2)

Publication Number Publication Date
JPS597163A JPS597163A (ja) 1984-01-14
JPH038322B2 true JPH038322B2 (https=) 1991-02-05

Family

ID=14650564

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57114946A Granted JPS597163A (ja) 1982-07-02 1982-07-02 抗動脈硬化剤

Country Status (2)

Country Link
US (1) US4565823A (https=)
JP (1) JPS597163A (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US4920101A (en) * 1987-09-30 1990-04-24 Nelson Research & Development Co. Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
US4879275A (en) * 1987-09-30 1989-11-07 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agent
EP0355234A1 (en) * 1988-08-25 1990-02-28 Merrell Dow Pharmaceuticals Inc. Pyrazolopyridine derivatives as antiatherosclerotic and antihypercholesterolemic agents
IT1244728B (it) * 1991-02-13 1994-08-08 Glaxo Spa Impiego medicamentoso di derivati diidropiridinici
US7056286B2 (en) * 2003-11-12 2006-06-06 Adrian Ravenscroft Medical device anchor and delivery system
WO2011056981A2 (en) * 2009-11-04 2011-05-12 Nitinol Devices And Components, Inc. Alternating circumferential bridge stent design and methods for use thereof
WO2012047308A1 (en) * 2010-10-08 2012-04-12 Nitinol Devices And Components, Inc. Alternating circumferential bridge stent design and methods for use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4150119A (en) * 1976-10-22 1979-04-17 Jesus Emilio Lince Isaza Method for treatment of vascular disease
US4177278A (en) * 1977-04-05 1979-12-04 Bayer Aktiengesellschaft 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material

Also Published As

Publication number Publication date
US4565823A (en) 1986-01-21
JPS597163A (ja) 1984-01-14

Similar Documents

Publication Publication Date Title
JPH038322B2 (https=)
JP4095676B2 (ja) 注意障害を治療するためのコリンエステラーゼ阻害剤の使用
JP2006506425A5 (https=)
JP2006501295A5 (https=)
KR950702420A (ko) 알레르기 질환 치료를 위한 테르페나딘 대사물과 그것의 광학 순수 이성체(terfenadine metabolites and their optically pure isomers for treating allergic disorders)
JP2005511592A5 (https=)
JP2005506348A5 (https=)
RU2009121774A (ru) Пиридильное неароматическое азотсодержащее гетероцикло-1-карбоксилатное производное
JP2004524316A5 (https=)
JPH10279578A5 (https=)
KR950704314A (ko) 1,8-나프티리딘-2-온 유도체 및 그 사용 방법(1,8-naphthyridin-2-one derivative and use thereof)
CN1056143C (zh) 哌啶衍生物及其应用
JP2007501270A5 (https=)
JP2005526051A5 (https=)
JP2020509043A5 (https=)
RU99119911A (ru) Сшитые виниловые полимеры, способные адсорбировать желчные кислоты, исходные соединения, способы их получения, смеси полимеров и лекарственное средство
JP2006510659A5 (https=)
CA2539070A1 (en) Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
JP2007509946A5 (https=)
FR2573657A1 (fr) Produit comprenant une substance antiprogestomimetique et une substance uterotonique
JP2001523644A5 (https=)
JPH0262531B2 (https=)
JP2021529189A5 (https=)
JP2004519441A5 (https=)
RU98107807A (ru) Новые гетероциклические соединения